Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Receptor activator of NF-κB ligand (RANKL) triggers the differentiation of bone marrow-derived monocyte/macrophage precursor cells (BMMs) of hematopoietic origin into osteoclasts through the activation of mitogen-activated protein (MAP) kinases and transcription factors. Recently, reactive oxygen species (ROS)and antioxidant enzymes were shown to be closely associated with RANKL-mediated osteoclast differentiation. Although glutaredoxin2(Glrx2) plays a role in cellular redox homeostasis, its role in RANKL-mediated osteoclastogenesis is unclear. We found that Glrx2 isoform b (Glrx2b) expression is induced during RANKLmediated osteoclastogenesis. Over-expression of Glrx2b strongly enhanced RANKL- mediated osteoclastogenesis. In addition,Glrx2b-transduced BMMs enhanced the expression of key transcription factors c-Fos and NFATc1, but pre-treatment with SB203580, a p38-specific inhibitor, completely blocked this enhancement. Conversely, down-regulation of Glrx2b decreased RANKL- mediated osteoclastogenesis and the expression of c-Fos and NFATc1 proteins. Also, Glrx2b down-regulation attenuated the RANKL-induced activation of p38. Taken together, these results suggest that Glrx2b enhances RANKL-induced osteoclastogenesis via p38 activation. [BMB reports 2012; 45(3): 171-176]
Abstract
Receptor activator of NF-κB ligand (RANKL) triggers the differentiation of bone marrow-derived monocyte/macrophage precursor cells (BMMs) of hematopoietic origin into osteoclasts through the activation of mitogen-activated protein (MAP) kinases and transcription factors. Recently, reactive oxygen species (ROS)and antioxidant enzymes were shown to be closely associated with RANKL-mediated osteoclast differentiation. Although glutaredoxin2(Glrx2) plays a role in cellular redox homeostasis, its role in RANKL-mediated osteoclastogenesis is unclear. We found that Glrx2 isoform b (Glrx2b) expression is induced during RANKLmediated osteoclastogenesis. Over-expression of Glrx2b strongly enhanced RANKL- mediated osteoclastogenesis. In addition,Glrx2b-transduced BMMs enhanced the expression of key transcription factors c-Fos and NFATc1, but pre-treatment with SB203580, a p38-specific inhibitor, completely blocked this enhancement. Conversely, down-regulation of Glrx2b decreased RANKL- mediated osteoclastogenesis and the expression of c-Fos and NFATc1 proteins. Also, Glrx2b down-regulation attenuated the RANKL-induced activation of p38. Taken together, these results suggest that Glrx2b enhances RANKL-induced osteoclastogenesis via p38 activation. [BMB reports 2012; 45(3): 171-176]
참고문헌 (23)
- Boyle, W. J., "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
- Galibert, L., "The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily", J. Biol. Chem., 273, pp.34120~34127 (1998)
- Rao, A., "Transcription factors of the NFAT family: regulation and function", Annu. Rev. Immunol., 15, pp.707~747 (1997)
- Takayanagi, H., "Mechanistic insight into osteoclast differentiation in osteoimmunology", J. Mol. Med., 83, pp.170~179 (2005)
- Takayanagi, H., "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems", Nat. Rev. Immunol., 7, pp.292~304 (2007)
- Dröge, W., "Free radicals in the physiological control of cell function", Physiol. Rev., 82, pp.47~95 (2002)
- Lee, N. K., "A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation", BLOOD, 106, pp.852~859 (2005), AMER SOC HEMATOLOGY
- Fraser, J. H., "Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae", Bone, 19, pp.223~226 (1996)
- Kim, H., "Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts", FEBS Lett., 580, pp.5661~5665 (2006)
- Huh, Y. J., "Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors", CELL DEATH AND DIFFERENTIATION, 13, pp.1138~1146 (2006), NATURE PUBLISHING GROUP
- Lean, J., "Thioredoxin-1 mediates osteoclast stimulation by reactive oxygen species", Biochem. Biophys. Res. Commun., 321, pp.845~850 (2004)
- Gallogly, M. M., "Kinetic and mechanistic characterization and versatile catalytic properties of mammalian glutaredoxin 2: implications for intracellular roles", Biochemistry, 47, pp.11144~11157 (2008)
- Enoksson, M., "Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release", Biochem. Biophys. Res. Commun., 327, pp.774~779 (2005)
- Lillig, C. H., "Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide", Proc. Natl. Acad. Sci. U.S.A., 101, pp.13227~13232 (2004)
- Hudemann, C., "Identification, expression pattern, and characterization of mouse glutaredoxin 2 isoforms", Antioxid Redox Signal, 11, pp.1~14 (2009)
- Theill, L. E., "RANK-L and RANK: T cells, bone loss, and mammalian evolution", Annu. Rev. Immunol., 20, pp.795~823 (2002)
- Takayanagi, H., "Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts", Dev. Cell., 3, pp.889~901 (2002)
- Kim, K., "NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)", Molecular Endocrinology, 22(1), pp.176~185 (2008), The Endocrine Society
- Kim, K., "MafB negatively regulates RANKL-mediated osteoclast differentiation", BLOOD, 109(8), pp.3253~3259 (2007), AMER SOC HEMATOLOGY
- Huang, H., "Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway", Biochem. Biophys. Res. Commun., 351, pp.99~105 (2006)
- Kim, M. S., "RANKL-mediated Reactive Oxygen Species Pathway That Induces Long Lasting Ca(2+) Oscillations Essential for Osteoclastogenesis", JOURNAL OF BIOLOGICAL CHEMISTRY, 285(10), pp.6913~6921 (2010), AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
- Sen, C. K., "Redox signaling and the emerging therapeutic potential of thiol antioxidants", Biochem. Pharmacol., 55, pp.1747~1758 (1998)
- Ha, H., "Reactive oxygen species mediate RANK signaling in osteoclasts", EXPERIMENTAL CELL RESEARCH, 301, pp.119~127 (2004), ELSEVIER INC